Latest Articles
- Avoiding adverse drug effects in elderly patients
A working knowledge of pharmacokinetics and pharmacodynamics pays off in avoiding adverse drug effects in vulnerable patients.
- The current role of amiodarone in patients with congestive heart failure
Amiodarone is the antiarrhythmic agent of choice for patients with congestive heart failure, but its clinical benefit remains unproved.
- Upper gastrointestinal bleeding in a 41-year-old woman
What is the likely cause of this patient’s symptoms? A self-quiz on a clinical case.
- Hepatitis C update: Implications of the blood transfusion “lookback”
In the coming years, physicians will have to inform up to 300,000 blood recipients that they may have contracted hepatitis C.
- Lipid formulations of amphotericin B
New lipid formulations of amphotericin B are less nephrotoxic and can he given in higher doses than standard formulations, but improved efficacy has not been proved. With an illustration explaining the pharmacokinetics of these preparations.
- Our new understanding of heart failure: The role of beta-blockers in treatment
Beta-blockers can stop the downward spiral of heart failure by improving the biology of the myocyte. With an illustration showing the abnormal remodeling process in heart failure.